LingVo.club
Level
Needle-free spray delivers last-resort antibiotics — Level B1 — a group of white balls on a red background

Needle-free spray delivers last-resort antibioticsCEFR B1

24 Feb 2026

Adapted from Brian Consiglio-U. Missouri, Futurity CC BY 4.0

Photo by masakazu sasaki, Unsplash

Level B1 – Intermediate
3 min
137 words

New research describes a needle-free spray-mist device that can deliver last-resort antibiotics directly into infected tissue. Hongmin Sun of the University of Missouri led the work and the team tested the approach in a recent study with help from an industry partner.

Researchers used the device to treat MRSA and to deliver vancomycin into infected tissue without producing typical side effects such as kidney damage. The spray-mist differs from topical creams, which can be wiped away, and from bloodstream delivery, which exposes organs to high drug levels.

The device uses a patented design and the findings support further study. The researchers say the technology could help in wound care for people with diabetic foot ulcers or soldiers injured in battle, and it could lead to future clinical trials as they seek FDA approval.

Difficult words

  • antibioticdrugs that kill or stop bacteria growth
    antibiotics
  • vancomycinan antibiotic used when others fail
  • tissuethe material that makes up body parts
  • deliverto take something to a place or person
  • topicalapplied to the skin surface, not inside
  • bloodstreamthe flow of blood inside a person's body
  • patentto give legal protection for an invention
    patented
  • clinical trialresearch study to test medicines or treatments
    clinical trials

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • Would you prefer a needle-free treatment for a wound? Why or why not?
  • What are the main advantages of delivering antibiotics directly into infected tissue?
  • How could this device change care for soldiers or people with diabetes?

Related articles

Tofersen slows a rare form of ALS — Level B1
26 Dec 2025

Tofersen slows a rare form of ALS

A long-term study shows that tofersen, a drug for a rare genetic form of ALS, can slow disease progression and help some people improve. The trial followed participants for several years and recorded benefits and side effects.